Improving understanding and treatment of lupus nephritis
Official title: Core C- BIDMC Core
Funded at Beth Israel Deaconess Medical Center · NIH-11046582 · Data updated 2026-11-12
This study is working on improving how we manage and treat lupus nephritis by using new technologies and teamwork to gather and analyze important information, all with the goal of helping patients feel better faster.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | March 1, 2024 |
| Project end | February 28, 2029 |
| Funding year | 2025 |
| Award (this year) | $227,481 |
| NIH project number | 5P01AI179405-02 |
| Project ID | NIH-11046582 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with lupus nephritis who are seeking innovative treatment options.
✕Less likely to help
Patients with conditions unrelated to lupus nephritis may not receive any benefit from this research.
What this research studies
This research focuses on enhancing the management and treatment of lupus nephritis by utilizing advanced technologies and interdisciplinary expertise. It aims to streamline the processes of sample processing, data generation, and integration, which are critical for understanding this condition. The project will implement best practices in data management and ensure high-quality data collection through automated profiling techniques. By collaborating with various cores and personnel, the research seeks to deliver timely and efficient data that can lead to better patient outcomes.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and management of lupus nephritis, potentially enhancing the quality of life for patients.
How similar studies have gone: Previous research has shown success in utilizing advanced data processing techniques for similar autoimmune conditions, indicating a promising approach.
Where this research is happening
-
Beth Israel Deaconess Medical Center
Boston, United States Active
Researchers
- Principal investigator: Vlachos, Ioannis — Beth Israel Deaconess Medical Center
- Study coordinator: Vlachos, Ioannis
Related research
Other NIH-funded projects on the same topics.
-
SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers
This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.
-
Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study
This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.
-
Statin use after brain bleed: SATURN MRI ancillary study
This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.
-
XenCAT: Single Cell Atlas for Xenopus
Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.
-
Statin use after lobar intracerebral hemorrhage
This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.
-
Statin use after lobar brain hemorrhage
This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.